Analyst firms · H.C. Wainwright · ASND

H.C. Wainwright ASND price target and rating history

Ascendis Pharma A/S (ASND) · Health Care

H.C. Wainwright rates Ascendis Pharma A/S (ASND) Buy with a $345 price target, as of its latest action on Aug 27, 2026. It has published 3 rating actions on ASND since August 2021, including 0 upgrades and 0 downgrades. Across 6 firms with a ASND price target in the last 12 months, the median target is $330.50. H.C. Wainwright's $345 is 4% above that.

Current rating

Buy

Price target

$345

Median target, all firms

$330.50

Actions on ASND

3

H.C. Wainwright price target on ASND

Every H.C. Wainwright rating on ASND

• Aug 27, 2026
  InitiateH.C. Wainwright starts coverage at Buy, price target $345
• Jan 27, 2022
  ReiterateH.C. Wainwright raises its price target to $0.40 from $0.35, keeps Buy
• Aug 19, 2021
  ReiterateH.C. Wainwright cuts its price target to $0.35 from $0.40, keeps Buy

How other firms rate ASND

Each firm's latest rating and stated target in the last 12 months.

Questions about H.C. Wainwright and ASND

What is H.C. Wainwright's price target for ASND?

H.C. Wainwright's latest stated price target for Ascendis Pharma A/S (ASND) is $345, from its action on Aug 27, 2026.

What is H.C. Wainwright's rating on ASND?

H.C. Wainwright rates ASND Buy, a bullish rating, as of Aug 27, 2026.

When did H.C. Wainwright last change its view on ASND?

On Aug 27, 2026, H.C. Wainwright starts coverage at Buy, price target $345.

How does H.C. Wainwright's ASND target compare with other analysts?

Across 6 firms with a ASND price target in the last 12 months, the median target is $330.50. H.C. Wainwright's $345 is 4% above that.

More ASND rating histories

• Morgan Stanley5
• Oppenheimer3
• Credit Suisse5

All H.C. Wainwright ratingsASND news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.